Numerous studies have demonstrated that niclosamide possesses potent anti-cancer properties, including anti-proliferative and pro-apoptotic effects, along with activity as a STAT3 inhibitor and a negative regulator of Programmed Death-Ligand 1 protein, which may potentiate immunotherapeutic responses [69,70,71,72,73,74]. Here, STAT3 is linked to cancer.